Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2025-12-25 @ 1:45 AM
NCT ID:
NCT06033794
Eligibility Criteria:
Inclusion Criteria:
* Patients aged between 18 and 75 years
* Colonoscopic biopsy confirmed colorectal adenocarcinoma
* The tumor was located in the rectum or upper rectum, and the surgical method was Dxion
* No local complications before operation (no obstruction, incomplete obstruction, no massive active bleeding, no perforation, abscess formation, no local invasion)
* Preoperative imaging diagnosis was cT1-4aNxM0
* The hematopoietic functions of heart, lung, liver, kidney and bone marrow meet the requirements of surgery and anesthesia
* Sign the informed consent form
Exclusion Criteria:
* Previous surgical history of malignant colorectal tumors
* The surgical methods were combined abdominoperineal resection, Hartman operation and ISR operation
* There are contraindication of laparoscopic surgery, such as severe cardiopulmonary insufficiency
* Patients who have undergone multiple abdominal and pelvic surgeries or extensive abdominal adhesion
* Patients with intestinal obstruction, intestinal perforation, intestinal bleeding and other emergency operations
* ASA grade ≥IV and/or ECOG physical status score ≥2 points
* Patients with severe liver and kidney function, cardiopulmonary function, coagulation dysfunction or combined with serious underlying diseases can not tolerate surgery
* Have a history of serious mental illness
* Patients with uncontrolled infection before operation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06033794
Study Brief:
Protocol Section:
NCT06033794